Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Extragonadal germ cell tumor: a clinical study

M A Bassetto1, F Pasini, T Franceschi

  • 1Cattedra di Oncologia Medica, Università di Verona, Italy.

Anticancer Research
|November 1, 1995
PubMed
Summary

Cisplatin-based chemotherapy effectively treats primary extragonadal germ cell tumors, achieving high remission and long-term relapse-free survival rates in most patients. Survival outcomes were similar across different tumor locations and subtypes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early focal electroencephalogram and neuroimaging findings predict epilepsy development after aneurysmal subarachnoid hemorrhage.

Epilepsy & behavior : E&B·2024
Same author

Reference miRNAs for colorectal cancer: analysis and verification of current data.

Scientific reports·2017
Same author

Erratum to: Advances in systemic therapy for metastatic breast cancer: future perspectives.

Medical oncology (Northwood, London, England)·2017
Same author

Predictive genetic markers in neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: a long way to go. Review of the literature.

The pharmacogenomics journal·2017
Same author

Advances in systemic therapy for metastatic breast cancer: future perspectives.

Medical oncology (Northwood, London, England)·2017
Same author

Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Area of Science:

  • Oncology
  • Medical research

Background:

  • Extragonadal germ cell tumors (EGCTs) are rare neoplasms originating outside the gonads.
  • Primary EGCTs require specific treatment strategies due to their unique presentation and potential for metastasis.

Purpose of the Study:

  • To evaluate the efficacy of cisplatin-based chemotherapy in patients with primary extragonadal germ cell tumors.
  • To assess remission rates, relapse-free survival, and overall survival in this patient cohort.

Main Methods:

  • Retrospective analysis of 18 patients diagnosed with primary extragonadal germ cell tumors.
  • Treatment involved cisplatin-based chemotherapy for 17 patients.
  • Follow-up included assessment of remission status, relapse, and survival data.

Main Results:

Related Experiment Videos

  • Fifteen out of 18 patients (83%) achieved complete remission.
  • 12 patients remain relapse-free after a median follow-up of 82 months.
  • Five-year overall survival rate was 65%.

Conclusions:

  • Cisplatin-based chemotherapy is an effective treatment for primary extragonadal germ cell tumors.
  • Long-term remission and survival are achievable with this therapeutic approach.
  • No significant survival differences were observed based on tumor location (mediastinal vs. retroperitoneal) or histology (seminoma vs. non-seminoma).